YMC ChromaCon has a unique range of process and process control patents and together with our scale-up partner, YMC America, we offer chromatography solutions from laboratory to GMP process scale.

Our vision is to improve the efficiency of bioprocessing by providing best-in-class chromatography equipment to develop and manufacture the next-generation of chemical and biological medicines using continuous manufacturing technology. Continuous manufacturing offers 30-50% reduction in CAPEX and OPEX compared to conventional batch manufacturing.

We are unique in providing a twin-column FPLC development system, the Contichrom CUBE, for the continuous purification of peptides, oligonucleotides, mAbs, and small molecules. The Contichrom CUBE has multiple process capabilities allowing our customers to choose the best purification process for any given purification challenge. Chromatographic processes developed on the Contichrom CUBE can be scaled directly to any Contichrom TWIN, our line of GMP capable continuous manufacturing systems.

ChromaCon AG was founded in 2008 and acquired by YMC in 2019. Within the YMC Group, YMC ChromaCon is the center of excellence for developing and commercializing continuous chromatographic process technologies.
YMC ChromaCon is based in Switzerland but has a global footprint.


YMC ChromaCon

Org chart

Teams

Offices

YMC ChromaCon

Org chart

Teams

Offices

Related companies